Profile Detail
Hersh Sagreiya, MD
ResidentE-Mail:
Interest (in 3 to 10 words):
| Education | |
| Harvard (2003-07) | |
| Medical / Graduate School | Stanford (2007-12) |
| Residency | University of Pittsburgh Medical Center (2013-17) |
| Clinical / Post-doctoral Fellowship | |
| Current | |
| Specialties & Programs |
PET MR CT Interventional Translational |
| Clinical Interest | |
| Research Interest | Radiogenomics, Informatics, Quantitative Imaging |
| Selected Publications | Howe, P.D.L., Thompson, P.G., Anstis, S.M., Sagreiya, H., & Livingstone, M. S. (2006). Explaining the Footsteps, Bellydancer, Wenceslas, and Kickback Illusions. Journal of Vision, 6(12), 1396-1405, http://journalofvision.org/6/12/5/, doi:10.1167/6.12.5. Howe, P.D.L., Sagreiya, H., Curtis, D.L., Zheng, C., & Livingstone, M.S. (2007). The Double-anchoring Theory of Lightness Perception: A Comment on Bressan (2006). Psychological Review, 114(4), 1105-1110. International Warfarin Pharmacogenetics Consortium (2009). Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data. New England Journal of Medicine, 360(8), 753-764. Turcott, R.G., Sagreiya, H., Altman, R.B., Das, A.K (2009). A General Framework for Dose Optimization. AMIA Annual Symposium Proceedings, 2009, 656-60. Ashley, E.A., Butte, A.J., Wheeler, M.T., Chen, R., Klein, T.E., Dewey, F.E., Dudley, J.T., Ormond, K.E., Pavlovic, A., Hudgins, L., Gong, L., Hodges, L.M., Berlin, D.B., Thorn, C.F., Sangkuhl, K., Hebert, J.M., Woon, M., Sagreiya, H., Whaley, R., Morgan, A.A., Pushkarev, D., Neff, N.F., Knowles, J.W., Chou, M., Thakuria, J., Rosenbaum, A., Zaranek, A.W., Church, G., Greely, H.T., Quake, S.R., Altman, R.B. (2010). Clinical evaluation incorporating a personal genome. The Lancet, 375(9725), 1525-1535. Sagreiya, H., & Altman R.B. (2010). The utility of general purpose versus specialty clinical databases for research: warfarin dose estimation from extracted clinical variables. Journal of Biomedical Informatics, 43(5), 747-51, doi:10.1016/j.jbi.2010.03.014. Owen, R.P., Gong, L., Sagreiya, H., Klein, T.E., & Altman, R.B. (2010). VKORC1 Pharmacogenomics Summary. Pharmacogenetics and Genomics, 20(10), 642-4. Limdi, N.A., Wadelius, M., Cavallari, L., Eriksson, N., Crawford, D.C., Lee, M.M., Chen, C., Motsinger-Reif, A., Sagreiya, H., Liu, N., Wu, A.H.B, Gage, B.,F., Jorgensen, A., Pirmohamed, M., Shin, J., Suarez-Kurtz, G., Kimmel, S.E., Johnson, J.A., Klein, T.E., Wagner, M.J. (2010). Warfarin Pharmacogenetics: A single VKORC1 polymorphism is predictive of dose across three racial groups. Blood, 115(18):3827-34. Sagreiya, H., Wen, A., Berube, C., Mir, A., Ramakrishnan, R., Hamilton, A., & Altman, R.B. (2010). Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9. Pharmacogenetics and Genomics, 20(7), 407-13. Tatonetti, N.P., Dudley, J.T., Sagreiya, H., & Altman, R. B. (2010). An integrative method for scoring candidate genes from association studies: application to warfarin dosing. BMC Bioinformatics, 11(Suppl 9), S9, doi:10.1186/1471-2105-11-S9-S9. Danese E., Montagnana M., Johnson J.A., Rettie A.E., Zambon C.F., Lubitz S.A., Suarez-Kurtz G., Cavallari L.H., Zhao L., Huang M., Nakamura Y., Mushiroda T., Kringen M.K., Borgiani P., Ciccacci C., Au N.T., Langaee T., Siguret V., Loriot M.A., Sagreiya H., Altman R.B., Shahin M.H., Scott S.A., Khalifa S.I., Chowbay B., Suriapranata I.M., Teichert M., Stricker B.H., Taljaard M., Botton M.R., Zhang J.E., Pirmohamed M., Zhang X., Carlquist J.F., Horne B.D., Lee M.T., Pengo V., Guidi G.C., Minuz P., Fava C. (2012). Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis. Clinical Pharmacology and Therapeutics, 92(6), 746-56. Perera M.A., Cavallari L.H., Limdi N.A., Gamazon E.R., Konkashbaev A., Daneshjou R., Pluzhnikov A., Crawford D.C., Wang J., Liu N., Tatonetti N., Bourgeois S., Takahashi H., Bradford Y., Burkley B.M., Desnick R.J., Halperin J.L., Khalifa S.I., Langaee T.Y., Lubitz S.A., Nutescu E.A., Oetjens M., Shahin M.H., Patel S.R., Sagreiya H., Tector M., Weck K.E., Rieder M.J., Scott S.A., Wu A.H., Burmester J.K., Wadelius M., Deloukas P., Wagner M.J., Mushiroda T., Kubo M., Roden D.M., Cox N.J., Altman R.B., Klein T.E., Nakamura Y., Johnson J.A (2013). Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. The Lancet, 375(9725), 1525-1535. Daneshjou R., Tatonetti N.P., Karczewski K.J., Sagreiya H., Bourgeois S., Drozda K., Burmester J.K., Tsunoda T., Nakamura Y., Kubo M., Tector M., Limdi N.A., Cavallari L.H., Perera M., Johnson J.A., Klein T.E., Altman R.B. (2013). Pathway analysis of genome-wide data improves warfarin dose prediction. BMC Genomics, 2013, 14 Suppl 3, S11. |
| Honors and Awards |
Stanford Medical Student Research Symposium Award (2010) American Medical Association Seed Grant Research Program (2010) Howard Hughes Medical Institute Research Training Fellowship (2009-10) Stanford Medical Scholars Grants (2008-10) |
| PubMed Publications | See a listing of publications on PubMed, a service of the National Library of medicine. |
